NCT04300621View on ClinicalTrials.gov

A Study of Different Oral Thin Film (S)-Ketamine Formulations for Sublingual Administration in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 19, 2020

Primary Completion Date

August 10, 2020

Study Completion Date

August 10, 2020

Conditions
Healthy
Interventions
DRUG

OTF 1

Participants will receive (S)-ketamine administered sublingually through OTF 1.

DRUG

OTF 2

Participants will receive (S)-ketamine administered sublingually through OTF 2.

DRUG

OTF 3

Participants will receive (S)-ketamine administered sublingually through OTF 3.

DRUG

OTF 4

Participants will receive (S)-ketamine administered sublingually through OTF 4.

Trial Locations (1)

2060

SGS Life Science Services, Antwerp

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY

NCT04300621 - A Study of Different Oral Thin Film (S)-Ketamine Formulations for Sublingual Administration in Healthy Participants | Biotech Hunter | Biotech Hunter